Websites, domains, hosts that links to janssencarepath.com
Our database shows, that the website janssencarepath.com is linked by a total of 12 websites.
Number of websites/domains displayed: 12
Results found: 12
Websites discovered:
STELARA® (ustekinumab)http://pageoverview.com/website-report/stelarahcp.com
- Expected expiration: March 28th in 2018
- Creation date: March 28th in 2014
- Renew date: May 13th in 2017
XARELTO® (rivaroxaban) Information for Healthcare Professionals | XARELTO® (rivaroxaban) HCPhttp://pageoverview.com/website-report/xareltohcp.com
Discover XARELTO®, a Factor Xa inhibitor indicated to reduce stroke risk in patients with nonvalvular AF, to treat DVT & PE and for extended risk reduction, and for DVT prophylaxis after knee or hip replacement surgery.
- Expected expiration: September 5th in 2018
- Creation date: September 5th in 2008
- Renew date: September 1st in 2016
- Google Analytics: 6230610-8
Janssen CarePath for Patients and Caregivershttp://pageoverview.com/website-report/janssencarepathsavings.com
Janssen CarePath houses patient resources for cvm, id/v, oncology and immunology patients as well as cost support information.
- Expected expiration: December 21st in 2017
- Creation date: December 21st in 2015
- Renew date: November 20th in 2016
- Google Analytics: 70816641-12
Official Website for REMICADE® (infliximab)http://pageoverview.com/website-report/remicade.com
Learn about treatment with REMICADE® (infliximab) across all uses and see Important Safety Information and Medication Guide for discussion with your doctor.
- Expected expiration: June 23rd in 2017
- Creation date: June 24th in 1998
- Renew date: May 13th in 2017
- Google Analytics: 1863405-7
Biosimilar is not the same as REMICADE® (infliximab)http://pageoverview.com/website-report/finelytuned.com
Learn about staying on REMICADE® (infliximab) if asked to consider a switch to a biosimilar. See full Prescribing & Safety info.
- Expected expiration: May 10th in 2018
- Creation date: May 10th in 2002
- Renew date: March 6th in 2017
Treatment & Support | PREZCOBIX® (darunavir 800 mg/cobicistat 150 mg)http://pageoverview.com/website-report/prezcobix.com
Learn how treatment with once-daily PREZCOBIX® (darunavir 800 mg/cobicistat 150 mg) may affect CD4+ cell count. See full Prescribing & Safety info.
- Expected expiration: June 10th in 2018
- Creation date: June 10th in 2014
- Renew date: May 14th in 2017
- Google Analytics: 2050685-23
Janssen CarePath for Patients and Caregivershttp://pageoverview.com/website-report/janssencarepath.com
Janssen CarePath houses patient resources for cvm, id/v, oncology and immunology patients as well as cost support information.
- Expected expiration: March 21st in 2018
- Creation date: March 21st in 2011
- Renew date: May 12th in 2017
- Google Analytics: 70816641-12
ZYTIGA® (abiraterone acetate)http://pageoverview.com/website-report/zytiga.com
- Expected expiration: August 12th in 2018
- Creation date: August 12th in 2010
- Renew date: July 12th in 2017
- Google Analytics: 1863405-99
Plaque Psoriasis & Psoriatic Arthritis | STELARA® (ustekinumab)http://pageoverview.com/website-report/stelarainfo.com
Learn about moderate to severe plaque psoriasis & active psoriatic arthritis treatment STELARA®. See Full Prescribing Info & Important Safety Information.
- Expected expiration: December 4th in 2017
- Creation date: December 4th in 2008
- Renew date: May 13th in 2017
- Google Analytics: 1863405-87
Moderate to severe plaque psoriasis treatment | TREMFYA™ (guselkumab)http://pageoverview.com/website-report/tremfya.com
Learn about TREMFYA™ (guselkumab), which is approved for adult patients with moderate to severe plaque psoriasis. See full Prescribing Info & Important Safety Info
- Expected expiration: February 19th in 2019
- Creation date: February 19th in 2016
- Renew date: October 9th in 2017
- Google Analytics: 70816641-32